American Journal of Engineering & Natural Sciences (AJENS) ISSN 2074-112X

Original Research Contributions in Genetic Biongineering And Natural Genome Editing

fallback-image

Ci Darlaiani

Lab Reagents

All Competitors Laboratories manufactures the ci darlaiani reagents distributed by Genprice. The Ci Darlaiani reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact All Competitors. Other Ci products are available in stock. Specificity: Ci Category: Darlaiani

Serum / Plasma information

CI-943

HY-100161 5mg
EUR 3155

CI-1044

HY-100246 10mg
EUR 1706

CI-1040

HY-50295 50mg
EUR 422

CI-949

HY-U00364 5mg
EUR 4513

CI-1033 (Canertinib)

E1KS1019 25mg
EUR 247

CI-1040 (PD184352)

E1KS1020 5mg
EUR 325

CI 966 hydrochloride

B6677-10 10 mg
EUR 366

CI 966 hydrochloride

B6677-50 50 mg
EUR 1379

CI 898 trihydrochloride

B6934-10 10 mg
EUR 286

PD184352 (CI-1040)

A1792-100 100 mg
EUR 595
Description: PD184352 (also known as CI-1040), a benzhydroxamate derivative, is a potent and highly selective MEK1/2, two members of the family of MAPKKs, inhibitor that inhibits purified MEK1 with IC50 of 17 nM in a non-ATP and non-ERK1/2 competitive manner [1]

PD184352 (CI-1040)

A1792-25 25 mg
EUR 258
Description: PD184352 (also known as CI-1040), a benzhydroxamate derivative, is a potent and highly selective MEK1/2, two members of the family of MAPKKs, inhibitor that inhibits purified MEK1 with IC50 of 17 nM in a non-ATP and non-ERK1/2 competitive manner [1]

PD184352 (CI-1040)

A1792-5 5 mg
EUR 108
Description: PD184352 (also known as CI-1040), a benzhydroxamate derivative, is a potent and highly selective MEK1/2, two members of the family of MAPKKs, inhibitor that inhibits purified MEK1 with IC50 of 17 nM in a non-ATP and non-ERK1/2 competitive manner [1]

PD184352 (CI-1040)

A1792-5.1 10 mM (in 1mL DMSO)
EUR 113
Description: PD184352 (also known as CI-1040), a benzhydroxamate derivative, is a potent and highly selective MEK1/2, two members of the family of MAPKKs, inhibitor that inhibits purified MEK1 with IC50 of 17 nM in a non-ATP and non-ERK1/2 competitive manner [1]

Canertinib (CI-1033)

A1845-10 10 mg
EUR 108
Description: Canertinib (also known as CI-1033), a 3-chloro, 4-fluoro, 4-anilinoquinazoline, is an orally available, potent and irreversible Pan-erbB tyrosine kinase inhibitor that inhibits EGFR, HER2 and HER4 in vitro.

Canertinib (CI-1033)

A1845-100 100 mg
EUR 189
Description: Canertinib (also known as CI-1033), a 3-chloro, 4-fluoro, 4-anilinoquinazoline, is an orally available, potent and irreversible Pan-erbB tyrosine kinase inhibitor that inhibits EGFR, HER2 and HER4 in vitro.

Canertinib (CI-1033)

A1845-5.1 10 mM (in 1mL DMSO)
EUR 108
Description: Canertinib (also known as CI-1033), a 3-chloro, 4-fluoro, 4-anilinoquinazoline, is an orally available, potent and irreversible Pan-erbB tyrosine kinase inhibitor that inhibits EGFR, HER2 and HER4 in vitro.

Canertinib (CI-1033)

A1845-50 50 mg
EUR 148
Description: Canertinib (also known as CI-1033), a 3-chloro, 4-fluoro, 4-anilinoquinazoline, is an orally available, potent and irreversible Pan-erbB tyrosine kinase inhibitor that inhibits EGFR, HER2 and HER4 in vitro.

Recent Posts

June 2021
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  

Tags

Categories